Bulletin
Investor Alert

London Markets Open in:

Asia Markets Currencies US Market Snapshot

Novo Nordisk A/S ADR

NYS: NVO

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Novo Nordisk A/S ADR

After Hours

NVO
/zigman2/quotes/203484366/composite

$

92.00

Change

+0.21 +0.23%

Volume

Volume 27,964

Sep 26, 2023, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/203484366/composite

Previous close

$ 91.13

$ 91.79

Change

+0.66 +0.72%

Day low

Day high

$91.54

$92.97

Open
Open: 92.78

52 week low

52 week high

$48.59

$100.88

Open

Market cap

$356.26B

Average volume

3.91M

P/E ratio

21.80

Rev. per Employee

$521,882

EPS

4.21

Dividend

0.88

Div yield

0.80%

Ex dividend date

8/18/23

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/nvo

MarketWatch News on NVO

  1. Snack Stock Utz May Be a Buy, Says Analyst

    2:30 p.m. Sept. 26, 2023

    - Angela Palumbo

  2. Novo Nordisk partners with Valo Health on AI drug discovery

    8:28 a.m. Sept. 25, 2023

    - Eleanor Laise

  5. Medtech Makers Are Real Losers From Obesity Drugs

    9:25 a.m. Sept. 21, 2023

    - Bill Alpert

  6. Will Obesity Drugs Break the Healthcare System?

    9:16 a.m. Sept. 21, 2023

    - Josh Nathan-Kazis

  7. DoorDash Warns About Grocery Delivery: It’s Hard

    8:17 p.m. Sept. 8, 2023

    - Eric J. Savitz

  8. Food Stocks Have Gotten Hit Hard. 6 to Buy Now.

    5:54 p.m. Sept. 8, 2023

    - Andrew Bary

  11. ResMed shares can overcome obesity-drug craze, analysts say

    8:56 a.m. Sept. 6, 2023

    - Eleanor Laise

  14. Novo Nordisk Is Europe’s Biggest Company. Wegovy Helps.

    5:43 a.m. Sept. 5, 2023

    - Brian Swint

  15. First 10 Drugs Picked for Medicare Price Negotiations

    3:26 p.m. Aug. 29, 2023

    - Bill Alpert

  20. Amazon Pharmacy launches automatic coupons for $35 insulin

    9:07 a.m. Aug. 15, 2023

    - Eleanor Laise

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/nvo

Other News on NVO

  1. The Big Pharma Trade: Ozempic Is In, Covid-19 Is Out

    4:29 p.m. Sept. 26, 2023

    - Charley Grant

  2. A New Way to Protect Against Heart Attacks

    5:30 a.m. Sept. 23, 2023

    - Ron Winslow

  3. Contamination Found at Novo Nordisk Plant in U.S.

    9:34 a.m. Sept. 21, 2023

    - Peter Loftus

  4. Corrections & Amplifications

    6:53 p.m. Sept. 5, 2023

  5. Asian Markets Rise on China’s Property Stimulus Measures

    12:14 p.m. Sept. 4, 2023

    - Will Horner

  7. Drug Price Controls Mean Slower Cures

    6:44 p.m. Aug. 29, 2023

    - The Editorial Board

  8. Expensive Drugs Targeted for First U.S. Price Negotiations

    5:12 p.m. Aug. 29, 2023

    - Jared S. Hopkins

  9. Weight-Loss Drug Wegovy Also Works Against Heart Failure

    5:15 a.m. Aug. 25, 2023

    - Peter Loftus

  11. The Ozempic Craze Could Put These Companies on a Crash Diet

    5:30 a.m. Aug. 18, 2023

    - David Wainer

  16. Weight-Loss Drug Wegovy Cuts Heart Risk in New Study

    10:00 p.m. Aug. 8, 2023

    - Peter Loftus

  17. The Obesity Drug Revolution Just Got Real

    10:24 a.m. Aug. 8, 2023

    - David Wainer

  18. Drug Shortages Are a Boon to One Industry: Compounding Pharmacies

    9:00 a.m. Aug. 7, 2023

    - Jared S. Hopkins

  19. U.K. Reviews Safety of Ozempic, Other Weight-Loss Drugs

    3:38 p.m. July 26, 2023

    - Peter Loftus

  20. Drugs Like Ozempic Created a Gold Rush. These Drugmakers Want In.

    7:00 a.m. July 16, 2023

    - Jared S. Hopkins

  21. Loading more headlines...
/news/pressrelease/company/us/nvo

Press Releases on NVO

  13. JV Partner Liatam Mining Outlines Lithium Exploration Program

    9:19 a.m. Feb. 23, 2023

    - GlobeNewswire

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.